Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Non-opioid Pain Patch, Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Non-opioid Pain Patch Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Non-opioid Pain Patch Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Non-opioid Pain Patch Market Size Growth Rate by Type
    • 1.4.2 Lidocaine Patches
    • 1.4.3 Diclofenac Patches
    • 1.4.4 Methyl Salicylate Patches
    • 1.4.5 Capsaicin Patches
    • 1.4.6 Ketoprofen Patches
    • 1.4.7 Others
  • 1.5 Market by Application
    • 1.5.1 Global Non-opioid Pain Patch Market Size Growth Rate by Application
    • 1.5.2 Hospital Pharmacies
    • 1.5.3 Online Pharmacies
    • 1.5.4 Independent Pharmacies & Drug Stores
  • 1.6 Coronavirus Disease 2019 (Covid-19): Non-opioid Pain Patch Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Non-opioid Pain Patch Industry
      • 1.6.1.1 Non-opioid Pain Patch Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Non-opioid Pain Patch Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Non-opioid Pain Patch Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Non-opioid Pain Patch Market Size Estimates and Forecasts
    • 2.1.1 Global Non-opioid Pain Patch Revenue 2015-2026
    • 2.1.2 Global Non-opioid Pain Patch Sales 2015-2026
  • 2.2 Non-opioid Pain Patch Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Non-opioid Pain Patch Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Non-opioid Pain Patch Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Non-opioid Pain Patch Competitor Landscape by Players

  • 3.1 Non-opioid Pain Patch Sales by Manufacturers
    • 3.1.1 Non-opioid Pain Patch Sales by Manufacturers (2015-2020)
    • 3.1.2 Non-opioid Pain Patch Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Non-opioid Pain Patch Revenue by Manufacturers
    • 3.2.1 Non-opioid Pain Patch Revenue by Manufacturers (2015-2020)
    • 3.2.2 Non-opioid Pain Patch Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Non-opioid Pain Patch Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Non-opioid Pain Patch Revenue in 2019
    • 3.2.5 Global Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Non-opioid Pain Patch Price by Manufacturers
  • 3.4 Non-opioid Pain Patch Manufacturing Base Distribution, Product Types
    • 3.4.1 Non-opioid Pain Patch Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Non-opioid Pain Patch Product Type
    • 3.4.3 Date of International Manufacturers Enter into Non-opioid Pain Patch Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Non-opioid Pain Patch Market Size by Type (2015-2020)
    • 4.1.1 Global Non-opioid Pain Patch Sales by Type (2015-2020)
    • 4.1.2 Global Non-opioid Pain Patch Revenue by Type (2015-2020)
    • 4.1.3 Non-opioid Pain Patch Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Non-opioid Pain Patch Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Non-opioid Pain Patch Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Non-opioid Pain Patch Revenue Forecast by Type (2021-2026)
    • 4.2.3 Non-opioid Pain Patch Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Non-opioid Pain Patch Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Non-opioid Pain Patch Market Size by Application (2015-2020)
    • 5.1.1 Global Non-opioid Pain Patch Sales by Application (2015-2020)
    • 5.1.2 Global Non-opioid Pain Patch Revenue by Application (2015-2020)
    • 5.1.3 Non-opioid Pain Patch Price by Application (2015-2020)
  • 5.2 Non-opioid Pain Patch Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Non-opioid Pain Patch Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Non-opioid Pain Patch Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Non-opioid Pain Patch Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Non-opioid Pain Patch by Country
    • 6.1.1 North America Non-opioid Pain Patch Sales by Country
    • 6.1.2 North America Non-opioid Pain Patch Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Non-opioid Pain Patch Market Facts & Figures by Type
  • 6.3 North America Non-opioid Pain Patch Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Non-opioid Pain Patch by Country
    • 7.1.1 Europe Non-opioid Pain Patch Sales by Country
    • 7.1.2 Europe Non-opioid Pain Patch Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Non-opioid Pain Patch Market Facts & Figures by Type
  • 7.3 Europe Non-opioid Pain Patch Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Non-opioid Pain Patch by Region
    • 8.1.1 Asia Pacific Non-opioid Pain Patch Sales by Region
    • 8.1.2 Asia Pacific Non-opioid Pain Patch Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Non-opioid Pain Patch Market Facts & Figures by Type
  • 8.3 Asia Pacific Non-opioid Pain Patch Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Non-opioid Pain Patch by Country
    • 9.1.1 Latin America Non-opioid Pain Patch Sales by Country
    • 9.1.2 Latin America Non-opioid Pain Patch Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Non-opioid Pain Patch Market Facts & Figures by Type
  • 9.3 Central & South America Non-opioid Pain Patch Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Non-opioid Pain Patch by Country
    • 10.1.1 Middle East and Africa Non-opioid Pain Patch Sales by Country
    • 10.1.2 Middle East and Africa Non-opioid Pain Patch Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Non-opioid Pain Patch Market Facts & Figures by Type
  • 10.3 Middle East and Africa Non-opioid Pain Patch Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Acorda Therapeutics
    • 11.1.1 Acorda Therapeutics Corporation Information
    • 11.1.2 Acorda Therapeutics Description, Business Overview and Total Revenue
    • 11.1.3 Acorda Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Acorda Therapeutics Non-opioid Pain Patch Products Offered
    • 11.1.5 Acorda Therapeutics Recent Development
  • 11.2 ALLERGAN
    • 11.2.1 ALLERGAN Corporation Information
    • 11.2.2 ALLERGAN Description, Business Overview and Total Revenue
    • 11.2.3 ALLERGAN Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 ALLERGAN Non-opioid Pain Patch Products Offered
    • 11.2.5 ALLERGAN Recent Development
  • 11.3 Endo International
    • 11.3.1 Endo International Corporation Information
    • 11.3.2 Endo International Description, Business Overview and Total Revenue
    • 11.3.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Endo International Non-opioid Pain Patch Products Offered
    • 11.3.5 Endo International Recent Development
  • 11.4 GlaxoSmithKline
    • 11.4.1 GlaxoSmithKline Corporation Information
    • 11.4.2 GlaxoSmithKline Description, Business Overview and Total Revenue
    • 11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 GlaxoSmithKline Non-opioid Pain Patch Products Offered
    • 11.4.5 GlaxoSmithKline Recent Development
  • 11.5 Hisamitsu Pharmaceutical
    • 11.5.1 Hisamitsu Pharmaceutical Corporation Information
    • 11.5.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue
    • 11.5.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Hisamitsu Pharmaceutical Non-opioid Pain Patch Products Offered
    • 11.5.5 Hisamitsu Pharmaceutical Recent Development
  • 11.6 IBSA Institut Biochimque
    • 11.6.1 IBSA Institut Biochimque Corporation Information
    • 11.6.2 IBSA Institut Biochimque Description, Business Overview and Total Revenue
    • 11.6.3 IBSA Institut Biochimque Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 IBSA Institut Biochimque Non-opioid Pain Patch Products Offered
    • 11.6.5 IBSA Institut Biochimque Recent Development
  • 11.7 Mylan
    • 11.7.1 Mylan Corporation Information
    • 11.7.2 Mylan Description, Business Overview and Total Revenue
    • 11.7.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Mylan Non-opioid Pain Patch Products Offered
    • 11.7.5 Mylan Recent Development
  • 11.8 Pfizer
    • 11.8.1 Pfizer Corporation Information
    • 11.8.2 Pfizer Description, Business Overview and Total Revenue
    • 11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Pfizer Non-opioid Pain Patch Products Offered
    • 11.8.5 Pfizer Recent Development
  • 11.9 TEH SENG Pharmaceutical Mfg
    • 11.9.1 TEH SENG Pharmaceutical Mfg Corporation Information
    • 11.9.2 TEH SENG Pharmaceutical Mfg Description, Business Overview and Total Revenue
    • 11.9.3 TEH SENG Pharmaceutical Mfg Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 TEH SENG Pharmaceutical Mfg Non-opioid Pain Patch Products Offered
    • 11.9.5 TEH SENG Pharmaceutical Mfg Recent Development
  • 11.10 Teikoku Seiyaku
    • 11.10.1 Teikoku Seiyaku Corporation Information
    • 11.10.2 Teikoku Seiyaku Description, Business Overview and Total Revenue
    • 11.10.3 Teikoku Seiyaku Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Teikoku Seiyaku Non-opioid Pain Patch Products Offered
    • 11.10.5 Teikoku Seiyaku Recent Development
  • 11.1 Acorda Therapeutics
    • 11.1.1 Acorda Therapeutics Corporation Information
    • 11.1.2 Acorda Therapeutics Description, Business Overview and Total Revenue
    • 11.1.3 Acorda Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Acorda Therapeutics Non-opioid Pain Patch Products Offered
    • 11.1.5 Acorda Therapeutics Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Non-opioid Pain Patch Market Estimates and Projections by Region
    • 12.1.1 Global Non-opioid Pain Patch Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Non-opioid Pain Patch Revenue Forecast by Regions 2021-2026
  • 12.2 North America Non-opioid Pain Patch Market Size Forecast (2021-2026)
    • 12.2.1 North America: Non-opioid Pain Patch Sales Forecast (2021-2026)
    • 12.2.2 North America: Non-opioid Pain Patch Revenue Forecast (2021-2026)
    • 12.2.3 North America: Non-opioid Pain Patch Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Non-opioid Pain Patch Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Non-opioid Pain Patch Sales Forecast (2021-2026)
    • 12.3.2 Europe: Non-opioid Pain Patch Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Non-opioid Pain Patch Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Non-opioid Pain Patch Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Non-opioid Pain Patch Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Non-opioid Pain Patch Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Non-opioid Pain Patch Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Non-opioid Pain Patch Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Non-opioid Pain Patch Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Non-opioid Pain Patch Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Non-opioid Pain Patch Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Non-opioid Pain Patch Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Non-opioid Pain Patch Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Non-opioid Pain Patch Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Non-opioid Pain Patch Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Non-opioid Pain Patch Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Non-opioid Pain Patch Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Non-opioid Pain Patch market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-opioid Pain Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Non-opioid Pain Patch market is segmented into
    Lidocaine Patches
    Diclofenac Patches
    Methyl Salicylate Patches
    Capsaicin Patches
    Ketoprofen Patches
    Others

    Segment by Application, the Non-opioid Pain Patch market is segmented into
    Hospital Pharmacies
    Online Pharmacies
    Independent Pharmacies & Drug Stores

    Regional and Country-level Analysis
    The Non-opioid Pain Patch market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Non-opioid Pain Patch market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Non-opioid Pain Patch Market Share Analysis
    Non-opioid Pain Patch market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Non-opioid Pain Patch business, the date to enter into the Non-opioid Pain Patch market, Non-opioid Pain Patch product introduction, recent developments, etc.
    The major vendors covered:
    Acorda Therapeutics
    ALLERGAN
    Endo International
    GlaxoSmithKline
    Hisamitsu Pharmaceutical
    IBSA Institut Biochimque
    Mylan
    Pfizer
    TEH SENG Pharmaceutical Mfg
    Teikoku Seiyaku

    Buy now